Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Matthew D. Galsky, Enrique Grande, Arash Rezazadeh Kalebasty et al.|The Lancet|2020

Cited by 786